abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb

이 페이지는 한국어로 제공되지 않으며 English로 표시됩니다.

기사

2012년 7월 13일

저자:
Adeola Ajakaiye, BusinessDay [Nigeria]

Pfizer presents N19.6m to Kano drug test victim [Nigeria]

The Healthcare Meningitis Trust Fund, a corporate entity floated jointly by Pfizer Incorporated, and Kano State government, has presented a monetary compensation of N19.6 million to one of the victims of the Trovan drug in Kano. The beneficiary, Mohammed Mustapha, is the third batch of victims of the controversial drug test that have been compensated in the out-of-court settlement reached by parties involved in the dispute.

타임라인